ArticleJMIR research protocols2026
Integrating Physical Health Dimensions in Middle-Aged and Older Adults to Predict Drug Misuse and Relapse Through a Comprehensive Needs Model: Protocol for a Mixed Methods Study.
Article in JMIR research protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDrug misuse poses significant health risks, with rising prevalence globally, particularly affecting middle-aged and older adults. In Indonesia, drug misuse has complex impacts across physical, psychological, social, and spiritual dimensions. Addressing these issues is crucial as Indonesia transitions to an aging population.
objectiveThis study protocol aims to develop a comprehensive model incorporating physical health dimensions to predict drug misuse and relapse among middle-aged and older adults, grounded in the health belief model.
methodsWe will use a sequential mixed methods design, combining quantitative data from national databases and medical records with qualitative insights from stakeholders. The respondents will consist of three groups: (1) individuals with substance use disorders recruited from the Badan Narkotika Nasional (National Narcotics Agency), (2) participants from lembaga pemasyarakatan (penitentiary institutions) and balai pemasyarakatan (community correction centers), and (3) stakeholders involved in drug rehabilitation services and experts in the field of education. Data analysis will be conducted in sequential stages, including descriptive statistics, bivariate analysis, and logistic regression to identify predictors of relapse. Qualitative data will be analyzed using thematic analysis to explore stakeholders' perspectives.
resultsThis study was funded by the Ministry of Education, Culture, Research, and Technology of Indonesia in 2024. Data collection started in July 2024 and ended in December 2025. The study is structured into 3 phases. Upon completion, it is expected to support the development of a comprehensive model incorporating physical health dimensions to predict drug misuse and relapse among middle-aged and older adults, grounded in the health belief model. The findings are expected to be published by the end of 2026.
conclusionsThe study is expected to identify key health status indicators and levels of readiness to change for the prevention of drug misuse relapse, as well as to develop a preventive model that addresses the specific needs of vulnerable populations, thereby enhancing the effectiveness of intervention strategies. By using a holistic approach to address the multifaceted impacts of drug misuse, this study will aim to improve health outcomes for middle-aged and older adults. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/88987.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.